Recombinant mitochondrial transcription factor A protein inhibits nuclear factor of activated T cells signaling and attenuates pathological hypertrophy of cardiac myocytes

Mitochondrion

Volumn 12, Issue 4, 2012, Pages 449-458

  Fujino, Takeo ^a   Ide, Tomomi ^a   Yoshida, Masayoshi ^a   Onitsuka, Ken ^a   Tanaka, Atsushi ^a   Hata, Yuko ^a   Nishida, Motohiro ^b   Takehara, Takako ^a   Kanemaru, Takaaki ^c   Kitajima, Naoyuki ^b   Takazaki, Shinya ^a   Kurose, Hitoshi ^b   Kang, Dongchon ^a   Sunagawa, Kenji ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Cardiac hypertrophy; Mitochondrial transcription factor A; Nuclear factor of activated T cells

Indexed keywords

MITOCHONDRIAL DNA; MITOCHONDRIAL TRANSCRIPTION FACTOR A; RECOMBINANT MITOCHONDRIAL TRANSCRIPTION FACTOR A PROTEIN; RECOMBINANT PROTEIN; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE DOSAGE; HEART CELL CULTURE; HEART HYPERTROPHY; HEART INFARCTION; HEART MITOCHONDRION; HEART MUSCLE CELL; HYPERTROPHY; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELLS, CULTURED; DNA-BINDING PROTEINS; HUMANS; HYPERTROPHY; MALE; MICE; MITOCHONDRIAL PROTEINS; MYOCYTES, CARDIAC; NFATC TRANSCRIPTION FACTORS; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84863731701     PISSN: 15677249     EISSN: 18728278     Source Type: Journal    
DOI: 10.1016/j.mito.2012.06.002     Document Type: Article

References (34)

1. Alam T.I., Kanki T., Muta T., Ukaji K., Abe Y., Nakayama H., Takio K., Hamasaki N., Kang D. Human mitochondrial DNA is packaged with TFAM. Nucleic Acids Res. 2003, 31:1640-1645.
2. Aoki H., Richmond M., Izumo S., Sadoshima J. Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro. Biochem. J. 2000, 347(Pt 1):275-284.
3. Bernardi P. Mitochondrial transport of cations: channels, exchangers, and permeability transition. Physiol. Rev. 1999, 79:1127-1155.
4. Dai D.F., Chen T., Szeto H., Nieves-Cintron M., Kutyavin V., Santana L.F., Rabinovitch P.S. Mitochondrial targeted antioxidant peptide ameliorates hypertensive cardiomyopathy. J. Am. Coll. Cardiol. 2011, 58:73-82.
5. Dai D.F., Johnson S.C., Villarin J.J., Chin M.T., Nieves-Cintron M., Chen T., Marcinek D.J., Dorn G.W., Kang Y.J., Prolla T.A., Santana L.F., Rabinovitch P.S. Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure. Circ. Res. 2011, 108:837-846.
6. Frey N., Katus H.A., Olson E.N., Hill J.A. Hypertrophy of the heart: a new therapeutic target?. Circulation 2004, 109:1580-1589.
7. Fujii T., Onohara N., Maruyama Y., Tanabe S., Kobayashi H., Fukutomi M., Nagamatsu Y., Nishihara N., Inoue R., Sumimoto H., Shibasaki F., Nagao T., Nishida M., Kurose H. Galpha12/13-mediated production of reactive oxygen species is critical for angiotensin receptor-induced NFAT activation in cardiac fibroblasts. J. Biol. Chem. 2005, 280:23041-23047.
8. Gardin J.M., Lauer M.S. Left ventricular hypertrophy: the next treatable, silent killer?. JAMA 2004, 292:2396-2398.
9. Garnier A., Fortin D., Delomenie C., Momken I., Veksler V., Ventura-Clapier R. Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J. Physiol. 2003, 551:491-501.
10. Hayashi Y., Yoshida M., Yamato M., Ide T., Wu Z., Ochi-Shindou M., Kanki T., Kang D., Sunagawa K., Tsutsui H., Nakanishi H. Reverse of age-dependent memory impairment and mitochondrial DNA damage in microglia by an overexpression of human mitochondrial transcription factor a in mice. J. Neurosci. 2008, 28:8624-8634.
11. Ide T., Tsutsui H., Hayashidani S., Kang D., Suematsu N., Nakamura K., Utsumi H., Hamasaki N., Takeshita A. Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ. Res. 2001, 88:529-535.
12. Ikeuchi M., Matsusaka H., Kang D., Matsushima S., Ide T., Kubota T., Fujiwara T., Hamasaki N., Takeshita A., Sunagawa K., Tsutsui H. Overexpression of mitochondrial transcription factor a ameliorates mitochondrial deficiencies and cardiac failure after myocardial infarction. Circulation 2005, 112:683-690.
13. Iyer S., Thomas R.R., Portell F.R., Dunham L.D., Quigley C.K., Bennett J.P. Recombinant mitochondrial transcription factor A with N-terminal mitochondrial transduction domain increases respiration and mitochondrial gene expression. Mitochondrion 2009, 9:196-203.
14. Jin H., Hadri L., Palomeque J., Morel C., Karakikes I., Kaprielian R., Hajjar R., Lebeche D. KChIP2 attenuates cardiac hypertrophy through regulation of Ito and intracellular calcium signaling. J. Mol. Cell. Cardiol. 2010, 48:1169-1179.
15. Kalivendi S.V., Konorev E.A., Cunningham S., Vanamala S.K., Kaji E.H., Joseph J., Kalyanaraman B. Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: role of mitochondrial reactive oxygen species and calcium. Biochem. J. 2005, 389:527-539.
16. Kang D., Kim S.H., Hamasaki N. Mitochondrial transcription factor A (TFAM): roles in maintenance of mtDNA and cellular functions. Mitochondrion 2007, 7:39-44.
17. Kanki T., Ohgaki K., Gaspari M., Gustafsson C.M., Fukuoh A., Sasaki N., Hamasaki N., Kang D. Architectural role of mitochondrial transcription factor A in maintenance of human mitochondrial DNA. Mol. Cell. Biol. 2004, 24:9823-9834.
18. Karamanlidis G., Nascimben L., Couper G.S., Shekar P.S., del Monte F., Tian R. Defective DNA replication impairs mitochondrial biogenesis in human failing hearts. Circ. Res. 2010, 106:1541-1548.
19. Lagouge M., Argmann C., Gerhart-Hines Z., Meziane H., Lerin C., Daussin F., Messadeq N., Milne J., Lambert P., Elliott P., Geny B., Laakso M., Puigserver P., Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006, 127:1109-1122.
20. Larsson N.G., Wang J., Wilhelmsson H., Oldfors A., Rustin P., Lewandoski M., Barsh G.S., Clayton D.A. Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nat. Genet. 1998, 18:231-236.
21. Li H., Wang J., Wilhelmsson H., Hansson A., Thoren P., Duffy J., Rustin P., Larsson N.G. Genetic modification of survival in tissue-specific knockout mice with mitochondrial cardiomyopathy. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:3467-3472.
22. McKinsey T.A., Kass D.A. Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surface. Nat. Rev. Drug Discov. 2007, 6:617-635.
23. Molkentin J.D. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs. Cardiovasc. Res. 2004, 63:467-475.
24. Nishida M., Onohara N., Sato Y., Suda R., Ogushi M., Tanabe S., Inoue R., Mori Y., Kurose H. Galpha12/13-mediated up-regulation of TRPC6 negatively regulates endothelin-1-induced cardiac myofibroblast formation and collagen synthesis through nuclear factor of activated T cells activation. J. Biol. Chem. 2007, 282:23117-23128.
25. Nishida M., Watanabe K., Sato Y., Nakaya M., Kitajima N., Ide T., Inoue R., Kurose H. Phosphorylation of TRPC6 channels at Thr69 is required for anti-hypertrophic effects of phosphodiesterase 5 inhibition. J. Biol. Chem. 2010, 285:13244-13253.
26. Ohgaki K., Kanki T., Fukuoh A., Kurisaki H., Aoki Y., Ikeuchi M., Kim S.H., Hamasaki N., Kang D. The C-terminal tail of mitochondrial transcription factor a markedly strengthens its general binding to DNA. J. Biochem. 2007, 141:201-211.
27. Parisi M.A., Clayton D.A. Similarity of human mitochondrial transcription factor 1 to high mobility group proteins. Science 1991, 252:965-969.
28. Sakata Y., Masuyama T., Yamamoto K., Nishikawa N., Yamamoto H., Kondo H., Ono K., Otsu K., Kuzuya T., Miwa T., Takeda H., Miyamoto E., Hori M. Calcineurin inhibitor attenuates left ventricular hypertrophy, leading to prevention of heart failure in hypertensive rats. Circulation 2000, 102:2269-2275.
29. Thomas R.R., Khan S.M., Portell F.R., Smigrodzki R.M., Bennett J.P. Recombinant human mitochondrial transcription factor A stimulates mitochondrial biogenesis and ATP synthesis, improves motor function after MPTP, reduces oxidative stress and increases survival after endotoxin. Mitochondrion 2011, 11:108-118.
30. Tsutsumi T., Ide T., Yamato M., Kudou W., Andou M., Hirooka Y., Utsumi H., Tsutsui H., Sunagawa K. Modulation of the myocardial redox state by vagal nerve stimulation after experimental myocardial infarction. Cardiovasc. Res. 2008, 77:713-721.
31. van Rooij E., Doevendans P.A., Crijns H.J., Heeneman S., Lips D.J., van Bilsen M., Williams R.S., Olson E.N., Bassel-Duby R., Rothermel B.A., De Windt L.J. MCIP1 overexpression suppresses left ventricular remodeling and sustains cardiac function after myocardial infarction. Circ. Res. 2004, 94:e18-e26.
32. Vega R.B., Rothermel B.A., Weinheimer C.J., Kovacs A., Naseem R.H., Bassel-Duby R., Williams R.S., Olson E.N. Dual roles of modulatory calcineurin-interacting protein 1 in cardiac hypertrophy. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:669-674.
33. Wang J., Wilhelmsson H., Graff C., Li H., Oldfors A., Rustin P., Bruning J.C., Kahn C.R., Clayton D.A., Barsh G.S., Thoren P., Larsson N.G. Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial DNA gene expression. Nat. Genet. 1999, 21:133-137.
34. Wilkins B.J., Dai Y.S., Bueno O.F., Parsons S.A., Xu J., Plank D.M., Jones F., Kimball T.R., Molkentin J.D. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ. Res. 2004, 94:110-118.